January 15, 2026Open Access

Severity or Etiology?　― Reframing Cardiogenic Shock Management in the Era of Individualized Mechanical Circulatory Support ―

Key Points

Key points are not available for this paper at this time.

Abstract

priate?These decisions involve a delicate trade-off between timeliness, hemodynamic cost, and complication risks.Despite several consensus statements from Japan, 1 W hen encountering patients with cardiogenic shock (CS), clinicians face complex decisions regarding the initiation and management of temporary mechanical circulatory support (tMCS): Should pharmacological therapy be attempted first?Should tMCS be initiated early?If so, which device is most appro-

Bookmark

View Full Paper

Cite This Study

Takahiro Nakashima (Thu,) studied this question.

synapsesocial.com/papers/69d95d4c5e5bcb4e3b835c91 https://doi.org/https://doi.org/10.1253/circj.cj-25-1037